Preethi Venkat, MD, MPH
@preethivenkatmd.bsky.social
Gastroenterology fellow at UVA 💩👩🏾⚕️🩺
#Crohnie interested in #IBD & #publichealth
Charlottesville, VA 📍
#Crohnie interested in #IBD & #publichealth
Charlottesville, VA 📍
Pinned
Thank you to #AIBD for recognizing our work as the Best of AIBD Case Reports 2024!
🔑: #Alpha-gal syndrome may confer increased risk for first-dose infusion reaction to ustekinumab in pts with #IBD
💫: Pts who have an infusion reaction can safely tolerate SC ustekinumab injection 💉without issue
🔑: #Alpha-gal syndrome may confer increased risk for first-dose infusion reaction to ustekinumab in pts with #IBD
💫: Pts who have an infusion reaction can safely tolerate SC ustekinumab injection 💉without issue
Reposted by Preethi Venkat, MD, MPH
As 2024 draws to an end, several significant publications have advanced our understanding of inflammatory bowel disease treatment. Key studies offer important insights and a few are worth highlighting...
...continue reading at --> substack.com/home/post/p-...
#IBDSky #GISky
...continue reading at --> substack.com/home/post/p-...
#IBDSky #GISky
Notable IBD publications in 2024
As 2024 draws to an end, several significant publications have advanced our understanding of inflammatory bowel disease (IBD) treatment.
substack.com
December 14, 2024 at 7:53 AM
As 2024 draws to an end, several significant publications have advanced our understanding of inflammatory bowel disease treatment. Key studies offer important insights and a few are worth highlighting...
...continue reading at --> substack.com/home/post/p-...
#IBDSky #GISky
...continue reading at --> substack.com/home/post/p-...
#IBDSky #GISky
Thank you to #AIBD for recognizing our work as the Best of AIBD Case Reports 2024!
🔑: #Alpha-gal syndrome may confer increased risk for first-dose infusion reaction to ustekinumab in pts with #IBD
💫: Pts who have an infusion reaction can safely tolerate SC ustekinumab injection 💉without issue
🔑: #Alpha-gal syndrome may confer increased risk for first-dose infusion reaction to ustekinumab in pts with #IBD
💫: Pts who have an infusion reaction can safely tolerate SC ustekinumab injection 💉without issue
December 11, 2024 at 4:03 PM
Thank you to #AIBD for recognizing our work as the Best of AIBD Case Reports 2024!
🔑: #Alpha-gal syndrome may confer increased risk for first-dose infusion reaction to ustekinumab in pts with #IBD
💫: Pts who have an infusion reaction can safely tolerate SC ustekinumab injection 💉without issue
🔑: #Alpha-gal syndrome may confer increased risk for first-dose infusion reaction to ustekinumab in pts with #IBD
💫: Pts who have an infusion reaction can safely tolerate SC ustekinumab injection 💉without issue